IMUX
IMUX
NASDAQ · Biotechnology

Immunic Inc

$11.41
-0.19 (-1.64%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 13 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +116.4% upside
Low Target $14.59
Average Target $24.69
High Target $25.91
Current Price $11.41
Current
$11.41
Target
$24.69
$14.59 $24.69 avg $25.91
Scenario Analysis
Bear Case
$14.59
27.9%
Low target
Base Case
$24.69
+116.4%
Avg target
Bull Case
$25.91
+127.1%
High target
Risk/Reward
4.6x
Highly favorable
Price in Context
52-Week High
$15.10
-24.4% from high
52-Week Low
$5.06
+125.5% from low
Target vs 52W High
$24.69
+63.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +20.5%
AMGN
Amgen Inc
Hold 44 48% $190.87 -42.2%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +178.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +2.1%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -88.0%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -65.2%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -23.9%
BIIB
Biogen Inc
Buy 43 56% $91.45 -52.0%